日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

SGLT2 inhibitor empagliflozin ameliorates tubulointerstitial fibrosis in DKD by downregulating renal tubular PKM2.

SGLT2 抑制剂恩格列净通过下调肾小管 PKM2 来改善 DKD 中的肾小管间质纤维化

期刊:Cellular and Molecular Life Sciences
影响因子:6.2
doi:10.1007/s00018-025-05688-8
Cai Xiang, Cao Huanyi, Wang Meijun, Yu Piaojian, Liang Xiaoqi, Liang Hua, Xu Fen, Cai Mengyin
其它
发表日期：2025
文献求助 收藏

Pre-diabetes virtual health management community (VHMC) intervention and group interaction management model in China: a randomised clinical trial protocol

中国糖尿病前期虚拟健康管理社区（VHMC）干预和小组互动管理模式：一项随机临床试验方案

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2024-086268
Wang, Yifan; Hu, Xiling; Cheng, Li; Guo, Xiaodi; Cai, Mengyin; Liu, Shuhong; Zhang, Yao
糖尿病
代谢
发表日期：2024
文献求助 收藏

Dietary Knowledge, Attitude and Practice (KAP) Among the Family Members of Patients with Type 2 Diabetes Mellitus (T2DM) and Its Influence on the KAP of T2DM Patients

2型糖尿病患者家庭成员的饮食知识、态度和行为（KAP）及其对2型糖尿病患者KAP的影响

期刊:Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
影响因子:3
doi:10.2147/DMSO.S290639
Hu, Xiling; Zhang, Yao; Lin, Shuo; Guo, Xiaodi; Yang, Dan; Cai, Mengyin; Gao, Lingling
糖尿病
代谢
发表日期：2021
文献求助 收藏

Efficacy and Safety of a Decision Support Intervention for Basal Insulin Self-Titration Assisted by the Nurse in Outpatients with T2DM: A Randomized Controlled Trial

护士协助门诊2型糖尿病患者进行基础胰岛素自我滴定决策支持干预的有效性和安全性：一项随机对照试验

期刊:Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
影响因子:3
doi:10.2147/DMSO.S297913
Hu, Xiling; Deng, Hongrong; Zhang, Yao; Guo, Xiaodi; Cai, Mengyin; Ling, Cong; Li, Kun
代谢
糖尿病
免疫/内分泌
发表日期：2021
文献求助 收藏